Study Finds That Ibogaine May Mitigate Symptoms of Traumatic Brain Injuries

A study recently published by Stanford University shows that ibogaine, when paired with magnesium, can improve symptoms associated with traumatic brain injuries, such as depression, anxiety, memory loss, and post-traumatic stress disorder (“PTSD”).[1]   Ibogaine is a naturally occurring … Read more about Study Finds That Ibogaine May Mitigate Symptoms of Traumatic Brain Injuries

HHS Releases Support for Rescheduling Marijuana

Marijuana is currently classified as a Schedule I drug under the Controlled Substances Act (“CSA”), defined as a substance having “no currently accepted medical use” and “a high potential for abuse.” Other Schedule I substances include LSD and heroin. In late August 2023, the Department of Health … Read more about HHS Releases Support for Rescheduling Marijuana

IMPLICATIONS OF THE CORPORATE TRANSPARENCY ACT FOR SMALL BUSINESSES

The Corporate Transparency Act (the “CTA”) was passed as part of the National Defense Authorization Act, adopted by Congress January 1, 2021.[1] The CTA became effective on January 1, 2024, and will have an immense impact on corporate governance and structuring in the United States. Furthermore, it … Read more about IMPLICATIONS OF THE CORPORATE TRANSPARENCY ACT FOR SMALL BUSINESSES

The Corporate Transparency Act Reporting Exemptions

The Corporate Transparency Act mandates certain reporting requirements for beneficial ownership information for certain companies, with the goal of preventing the illicit use of anonymous shell companies for financial crimes. While the primary aim of the Corporate Transparency Act is to enhance … Read more about The Corporate Transparency Act Reporting Exemptions

The Corporate Transparency Act: An Overview

    The Corporate Transparency Act (the “CTA” or “Act”), enacted as part of the National Defense Authorization Act for Fiscal Year 2021, marks a significant shift in the regulatory framework for businesses in the United States. Presented as a tool to combat money laundering and … Read more about The Corporate Transparency Act: An Overview

SAFER Banking Act Passes Senate Committee in Historic Vote

On September 27, The SAFER Banking Act passed the Senate Banking Committee with a bipartisan vote of 14-9. The successful vote marks the first time a version of the cannabis banking legislation has passed a Senate Committee since it was first introduced in Congress all the way back in 2013. The bill … Read more about SAFER Banking Act Passes Senate Committee in Historic Vote